NYSE:TBI - Trueblue Stock Price, Price Target & More

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Trueblue declared that its board has approved a share buyback plan on Tuesday, October 31st 2017, which authorizes the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company's board of directors believes its stock is undervalued.

Trueblue Inc (NYSE:TBI) released its earnings results on Monday, April, 30th. The business services provider reported $0.31 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.22 by $0.09. The business services provider earned $554.39 million during the quarter, compared to the consensus estimate of $570.40 million. Trueblue had a net margin of 2.39% and a return on equity of 13.81%. The business's revenue was down 2.4% compared to the same quarter last year. During the same period last year, the company earned $0.21 earnings per share. View Trueblue's Earnings History.

Trueblue is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Trueblue.

Trueblue issued an update on its second quarter earnings guidance on Monday, April, 30th. The company provided EPS guidance of $0.47-0.53 for the period, compared to the Thomson Reuters consensus estimate of $0.53. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $627.25 million.

2 equities research analysts have issued 12-month price objectives for Trueblue's shares. Their predictions range from $26.00 to $29.00. On average, they expect Trueblue's share price to reach $27.50 in the next twelve months. This suggests a possible upside of 0.2% from the stock's current price. View Analyst Ratings for Trueblue.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Trueblue include ASGN (ASGN), Insperity (NSP), Dometic Group AB (publ) (DTCGF), AMN Healthcare Services (AMN), TTEC (TTEC), Kforce (KFRC), Kelly Services, Inc. Class B (KELYB), Kelly Services, Inc. Class A (KELYA), Barrett Business Services (BBSI), SThree (STREF), Cross Country Healthcare (CCRN), StarTek (SRT), DLH (DLHC), R C M Technologies (RCMT) and Hudson Global (HSON).

News articles about TBI stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Trueblue earned a news impact score of 0.10 on Accern's scale. They also gave media coverage about the business services provider an impact score of 45.96 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Trueblue's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.29%) and Alpha Windward LLC (0.05%). Company insiders that own Trueblue stock include Bonnie W Soodik, Derrek Lane Gafford, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Institutional Ownership Trends for Trueblue.

TBI stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can. Company insiders that have sold Trueblue company stock in the last year include Bonnie W Soodik, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Insider Buying and Selling for Trueblue.

TBI stock was purchased by a variety of institutional investors in the last quarter, including Alpha Windward LLC. View Insider Buying and Selling for Trueblue.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $27.45.

Trueblue has a market capitalization of $1.14 billion and generates $2.51 billion in revenue each year. The business services provider earns $55.45 million in net income (profit) each year or $1.74 on an earnings per share basis. Trueblue employs 5,500 workers across the globe.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]